Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
566-02-002 ISMRM Abstract

Quantitative Susceptibility Mapping Reveals Brainstem Iron Changes in Dementia with Lewy bodies

Primary: Contrast Mechanisms - Susceptibility/QSM
Secondary: Neuro - Dementia
566-02-002 · MRI Markers of Dementia · Wednesday, 13 May, 9:15 AM–10:10 AM · Digital Posters Row G
Keywords: Quantitative Susceptibility Mapping (QSM) Neurodegeneration Biomarker Dementia with Lewy Bodies Synucleinopathy Brainstem
Accepted
Lorenzo Motta 1, Greta Venturi1, Elettra Capogna1, Luisa Sambati2, Davide Braghittoni1, Lucia Guidi1, Annalena Venneri3, Federica Provini4, Micaela Mitolo1,3, Raffaele Lodi1,4, Caterina Tonon1,4
1Programma Neuroimmagini Funzionali e Molecolari, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy
2IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy
3Department of Medicine and Surgery, University of Parma, Parma, Italy
4Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy
Presenting Author: Lorenzo Motta

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Braak, H., Tredici, K.D., Rüb, U., de Vos, R.A.I., Jansen Steur, E.N.H., Braak, E., 2003. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiology of Aging 24, 197–211. https://doi.org/10.1016/S0197-4580(02)00065-9 [doi]
2. Boeve, B.F., Silber, M.H., Saper, C.B., Ferman, T.J., Dickson, D.W., Parisi, J.E., Benarroch, E.E., Ahlskog, J.E., Smith, G.E., Caselli, R.C., Tippman-Peikert, M., Olson, E.J., Lin, S.-C., Young, T., Wszolek, Z., Schenck, C.H., Mahowald, M.W., Castillo, P.R., Del Tredici, K., Braak, H., 2007. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 130, 2770–2788. https://doi.org/10.1093/brain/awm056 [doi]
3. McKeith, I.G., Boeve, B.F., Dickson, D.W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C.G., Bayston, A., Beach, T.G., Blanc, F., Bohnen, N., Bonanni, L., Bras, J., Brundin, P., Burn, D., Chen-Plotkin, A., Duda, J.E., El-Agnaf, O., Feldman, H., Ferman, T.J., ffytche, D., Fujishiro, H., Galasko, D., Goldman, J.G., Gomperts, S.N., Graff-Radford, N.R., Honig, L.S., Iranzo, A., Kantarci, K., Kaufer, D., Kukull, W., Lee, V.M.Y., Leverenz, J.B., Lewis, S., Lippa, C., Lunde, A., Masellis, M., Masliah, E., McLean, P., Mollenhauer, B., Montine, T.J., Moreno, E., Mori, E., Murray, M., O’Brien, J.T., Orimo, S., Postuma, R.B., Ramaswamy, S., Ross, O.A., Salmon, D.P., Singleton, A., Taylor, A., Thomas, A., Tiraboschi, P., Toledo, J.B., Trojanowski, J.Q., Tsuang, D., Walker, Z., Yamada, M., Kosaka, K., 2017. Diagnosis and management of dementia with Lewy bodies. Neurology 89, 88–100. https://doi.org/10.1212/WNL.0000000000004058 [doi]
4. Deistung, A., Schweser, F., Reichenbach, J.R., 2017. Overview of quantitative susceptibility mapping. NMR in Biomedicine 30, e3569. https://doi.org/10.1002/nbm.3569 [doi]
5. Ravanfar, P., Loi, S.M., Syeda, W.T., Van Rheenen, T.E., Bush, A.I., Desmond, P., Cropley, V.L., Lane, D.J.R., Opazo, C.M., Moffat, B.A., Velakoulis, D., Pantelis, C., 2021. Systematic Review: Quantitative Susceptibility Mapping (QSM) of Brain Iron Profile in Neurodegenerative Diseases. Front Neurosci 15, 618435. https://doi.org/10.3389/fnins.2021.618435 [doi]
6. Morris, G., Berk, M., Carvalho, A.F., Maes, M., Walker, A.J., Puri, B.K., 2018. Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases. Behavioural Brain Research 341, 154–175. https://doi.org/10.1016/j.bbr.2017.12.036 [doi]
7. Masaldan, S., Bush, A.I., Devos, D., Rolland, A.S., Moreau, C., 2019. Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration. Free Radical Biology and Medicine, Iron as Soul of Life on Earth Revisited: From Chemical Reaction, Ferroptosis to Therapeutics 133, 221–233. https://doi.org/10.1016/j.freeradbiomed.2018.09.033 [doi]
8. Edlow, BL; Kinney, HC (2023), Harvard Ascending Arousal Network Atlas – Version 2.0, Dryad Digital Repository, https://doi.org/10.5061/dryad.zw3r228d2 [doi]
9. Edlow BL, Takahashi E, Wu O, Benner T, Dai G, Bu L, Grant PE, Greer DM, Greenberg SM, Kinney HC, Folkerth RD. Neuroanatomic connectivity of the human ascending arousal system critical to consciousness and its disorders. J Neuropathol Exp Neurol. 2012 Jun;71(6):531-46. doi: 10.1097/NEN.0b013e3182588293. PMID: 22592840; PMCID: PMC3387430 [doi] [pmid]
10. QSM Consensus Organization Committee; Bilgic B, Costagli M, Chan KS, Duyn J, Langkammer C, Lee J, Li X, Liu C, Marques JP, Milovic C, Robinson SD, Schweser F, Shmueli K, Spincemaille P, Straub S, van Zijl P, Wang Y; ISMRM Electro-Magnetic Tissue Properties Study Group. Recommended implementation of quantitative susceptibility mapping for clinical research in the brain: A consensus of the ISMRM electro-magnetic tissue properties study group. Magn Reson Med. 2024 May;91(5):1834-1862. doi: 10.1002/mrm.30006. Epub 2024 Jan 21. PMID: 38247051; PMCID: PMC10950544 [doi] [pmid]
11. Nikparast, F., Ganji, Z., Danesh Doust, M. et al. Brain pathological changes during neurodegenerative diseases and their identification methods: How does QSM perform in detecting this process?. Insights Imaging 13, 74 (2022). https://doi.org/10.1186/s13244-022-01207-6 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/566-02-002